What happens to people diagnosed with tuberculosis? A population-based cohort

Epidemiology and Infection

Volumn 135, Issue 7, 2007, Pages 1069-1076

  Anyama, N ^a   Bracebridge, S ^b   Black, C ^b   Niggebrugge, A ^c   Griffin, S J ^d  

^a MAKERERE UNIVERSITY   (Uganda)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c Eastern Region Public Health Observatory   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIUM CULTURE; BIRTHPLACE; CHILD; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NEGRO; PATIENT COMPLIANCE; PROGNOSIS; SPUTUM EXAMINATION; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS MENINGITIS; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS PLEURISY; UNITED KINGDOM; UROGENITAL TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; TUBERCULOSIS, PULMONARY;

EID: 34748840249     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807007996     Document Type: Article

References (39)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997; 349: 1436-1442.
2. World Health Organisation. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva: World Health Organisation, 2003.
3. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367: 938-940.
4. Crofts J. Preliminary Annual Report on Tuberculosis Cases Reported in 2002 in England, Wales and Northern Ireland. London: CDSC Tuberculosis Section, Health Protection Agency, 2004.
5. Hawker JI, et al. Ecological analysis of ethnic differences in relation between tuberculosis and poverty. British Medical Journal 1999; 319: 1031-1034.
6. Delgado JC, et al. Ethnic-specific genetic associations with pulmonary tuberculosis. Journal of Infectious Disease 2002; 186 1463-1468.
7. Teale C, Goldman JM, Pearson SB. The association of age with the presentation and outcome of tuberculosis: A five-year survey. Age Ageing 1993; 22: 289-293.
8. Reider HL. Epidemiologic Basis of Tuberculosis Control, 1st edn. Paris: International Union Against Tuberculosis and Lung Disease, 1999.
9. Crofton J, Horne N, Miller F. Clinical Tuberculosis, 2nd edn. London: Macmillan Education Ltd, 1998.
10. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of practice 2000. Thorax 2000; 55: 887-901.
11. Hayward AC, et al. The molecular epidemiology of tuberculosis in inner London. Epidemiology and Infection 2002; 128: 175-184.
12. Alseda M, Godoy P. Factors associated with latent tuberculosis infection in the contacts of tuberculosis patients. Gaceta Sanitaria 2004; 18: 101-107.
13. Ponticiello A, et al. Risk factors for tuberculosis infection and disease. Monaldi Archives of Chest Disease 2002; 57: 169-172.
14. Antoine D, French C. First Annual Report on Tuberculosis Treatment Outcomes Surveillance in England, Wales and Northern Ireland: Outcome Results on Tuberculosis Cases Reported in 2001. London: CDSC Tuberculosis Section, Enhanced tuberculosis surveillance, Health Protection Agency, 2004.
15. Rose AMC. Tuberculosis treatment outcome surveillance in England, Wales and Northern Ireland: Protocol. United Kingdom: Advisory Committee for Tuberculosis Treatment Outcome Surveillance in England, Wales and N Ireland, 2004.
16. Doherty MJ, Spence DP, Davies PD. Trends in mortality from tuberculosis in England and Wales: Effect of age on deaths from non-respiratory disease. Thorax 1995; 50: 976-979.
17. Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. London: Croom Helm, 2004.
18. Zumla A, Mullan Z. Turning the tide against tuberculosis. Lancet 2006; 367: 877-878.
19. Lienhardt C, Rustomjee R. Improving tuberculosis control: An interdisciplinary approach. Lancet 2006; 367: 949-950.
20. Sharma SK, Liu JJ. Progress of DOTS in global tuberculosis control. Lancet 2006; 367: 951-952.
21. Chang KC, Leung CC, Tam CM. Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. International Journal of Tuberculosis and Lung Disease 2004; 8: 1492-1498.
22. Kaona FA, et al. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 2004; 4: 68.
23. Tulsky JP, et al. Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. International Journal of Tuberculosis and Lung Disease 2004; 8: 83-91.
24. Conaty SJ, et al. Reasons for low reported treatment success in notified tuberculosis patients from a London hospital according to new outcome reporting. Communicable Disease and Public Health 2004; 7: 73-76.
25. Albuquerque MF, et al. Prognostic factors for pulmonary tuberculosis outcome in Recife, Pernambuco, Brazil. Revista Panamericana de Salud Pública 2001; 9: 368-374.
26. Brainard D, et al. Long-term outcome of inpatients with tuberculosis assigned to outpatient therapy at a local clinic in New Orleans. Journal of Investigative Medicine 1997; 45: 381-387.
27. Helbling P, et al. Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Medical Weekly 2002; 132: 517-522.
28. Coker R. Just coercion? Detention of nonadherent tuberculosis patients. Annals of the New York Academy of Science 2001; 953 216-223.
29. Raviglione MC, Uplekar MW. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-955.
30. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53: 536-548.
31. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews 2003; Art. no: CD003343.
32. Garner P, Volmink J. Families help cure tuberculosis. Lancet 2006; 367: 878-879.
33. Centis R, Migliori GB. Evaluation of tuberculosis treatment results in Italy, report 1999. Monaldi Archives of Chest Disease 2002; 57: 297-305.
34. Samman Y, et al. Treatment outcome of tuberculosis among Saudi nationals: Role of drug resistance and compliance. Clinical Microbiology and Infection 2003; 9: 289-294.
35. Diel R, Niemann S. Outcome of tuberculosis treatment in Hamburg: A survey, 1997-2001. International Journal of Tuberculosis and Lung Disease 2003; 7: 124-131.
36. Santha T, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. International Journal of Tuberculosis and Lung Disease 2002; 6: 780-788.
37. Diez Ruiz-Navarro M, et al. Results of anti-tuberculosis treatment in six autonomous regions in Spain. Medicina Clinica (Barcelona) 2001; 117: 574-580.
38. Aliyu MH, Salihu HM, Ratard R. HIV infection and sputum-culture conversion in patients diagnosed with Mycobacterium tuberculosis: A population-based study. Wiener Klinische Wochenschrift 2003; 115: 340-346.
39. Rocha M, et al. The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen. European Respiratory Journal 2003; 21: 785-788.